Inhibiting m6A enrichment via METTL3 knockdown resulted in enhanced growth, self-renewal, and tumor progression of glioma stem-like cells (GSCs), as reported by Cui et al [27]. The gene discussed is METTL3; the disease is central nervous system cancer.